World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12616001042437
Date of registration: 04/08/2016
Prospective Registration: Yes
Primary sponsor: School of Physical Therapy, Cairo University
Public title: A comparison between low & medium frequencies of electrotherapy and ultrasound combined as a single modality in the management of trapezius upper fibers active trigger points
Scientific title: A comparison between low & medium frequencies of electrotherapy and ultrasound combined as a single modality in the management of trapezius upper fibers active trigger points in adults with acute mechanical neck pain
Date of first enrolment: 01/10/2016
Target sample size: 60
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12616001042437.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Egypt
Contacts
Name: A/Prof Mary Kamal Nassif Takla   
Address:  School of Physical therapy, Cairo university 7 Ahmed Elzaiat St. Ben Elsaryat - EI Dokki-Giza - Egypt. 11432 Egypt
Telephone: +201222817512
Email: marytakla@hotmail.com
Affiliation: 
Name: A/Prof Mary Kamal Nassif Takla   
Address:  School of Physical therapy, Cairo university 7 Ahmed Elzaiat St. Ben Elsaryat - EI Dokki-Giza - Egypt. 11432 Egypt
Telephone: +201222817512
Email: marytakla@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Subject’s age will range from 25-45 years old
2. In the initial clinical examination, the subject will have acute mechanical neck pain and will be referred from an orthopedic physician.
3. Subjects will have at least two active MTrPs in the upper trapezius; that corresponds to the same location and physical characteristics of Travel and Simon (1999)
4. Onset of pain of less than 3 months (Tsakitzidis et al., 2013).
5. Subjects will not have undergone application of any physiotherapy or medications to relieve pain.

Exclusion criteria: 1. Signs of cervical disc prolapse, radiculopathy, spondylolythesis, systemic disease migraine.
2. Other neurological, orthopedic conditions.
3. Pregnancy and pacemaker .
4. Onset of pain more than 3 months.


Age minimum: 25 Years
Age maximum: 45 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Physical Medicine / Rehabilitation - Physiotherapy
Mechanical Neck pain;active myofascial trigger points;
Mechanical Neck pain
active myofascial trigger points
Musculoskeletal - Other muscular and skeletal disorders
Intervention(s)
Combination Therapy is the simultaneous application of electrotherapy and ultrasound at the same time, used as a single modality. Electrotherapy used can be low frequency as transcutaneous electrical nerve stimulation (TENS) or medium frequency as amplitude modulated frequency (AMF; the bipolar technique of interferential therapy).

This study will be conducted at a private clinic located at Heliopolis, Egypt; to compare between the effect of medium (interferential current) and low frequency (TENS) combination therapy on the cervical range of motion (ROM) and pressure pain threshold (PPT) on upper fibers of trapezius trigger points. To ensure fidelity we explained the entire procedure to the patient; with its aims, and potential unpleasant sensation experience from TENS application and informed him that he has the right to withdraw at anytime during the study duration. 6 free sessions after the completion of the study will be offered to all participants to improve fidelity.

Randomized controlled pre-post experimental design will be used. Sixty patients from both gender will participate in the study after signing institutionally approved consent form prior to data collection. Subjects will be randomly assigned into three groups;

Group A: 20 subjects will receive medium frequency (AMF) combination therapy, progressive pressure release and passive stretch to the upper trapezius; 3 times per week for 4 weeks. Session duration will be approximately 30 minutes.

Group B: 20 subjects will receive low frequency (TENS) combination therapy, progressive pressure release and passive stretch to the upper trapezius; 3 times per week for 4 weeks. Session duration will be approximately 30 minutes.

Group C: control group; 20 subjects will receive sha
Primary Outcome(s)
pressure pain threshold obtained via an electronic pressure algometer[at the beginning of the 1rst session (baseline measure)
at the end of each session and at the end of the 4 week treatment program]
Secondary Outcome(s)
Active cervical range of motion; flexion, extension and side bending with a Smart phone Goniometer application [at the beginning of the 1rst session (baseline measure)
at the end of each session and at the end of the 4 week treatment program ]
Secondary ID(s)
None
Source(s) of Monetary Support
Mary Kamal Nassif Takla
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Institutional Review Board of Higher Education and Research of Cairo University
Status: Approved
Approval date:
Contact:
Supreme Council of Universities
Status: Approved
Approval date:
Contact:
The Board Council of Higher Education of the School of Physical Therapy, Cairo university
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history